Stents coronarios biodegradables impregnados en restauración vascular

Inicio
Noticias
Endoprótesis coronarias biodegradables impregnadas, un sueño hecho realidad

Endoprótesis coronarias biodegradables impregnadas, un sueño hecho realidad

Comunicate con el proveedor:

Contactar

!noticia guardada!

Factores de riesgo de infarto agudo del miocardio en América Latina. Rev Panam Salud Publica [serial on the Internet]. 2007 Dec [cited 2012 Sep 24] ; 22(6): 402-403. Disponible en: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007001100007&lng=en. http://dx.doi.org/10.1590/S1020-49892007001100007.
Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, et al. Risk factors for acute myocardial infarction in Latin America. Circulation. 2007;115:1067–74
Konstantinov, Igor E. Robert H. Goetz: the surgeon who performed the first successful clinical coronary artery bypass operation Ann Thorac Surg 2000 69: 1966-1972. Disponible en: http://ats.ctsnetjournals.org/cgi/content/full/69/6/1966
Kolesov V.I. Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris. J Thorac Cardiovasc Surg 1967;45:535-544.
Konstantinov IE. Vasilii I. Kolesov A Surgeon to Remember Tex Heart Inst J. 2004; 31(4): 349–358. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC548233/
Grüntzig A, et al. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979 Jul 12;301(2):61-8.
Sigwart U, et al. Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty. N Engl J Med 1987; 316:701-706
Serruys PW, et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. NEJM 1994; 331(8) Disponible en: http://www.nejm.org/doi/pdf/10.1056/NEJM199408253310801
Fischman DL, et al. A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease. N Engl J Med 1994; 331:496-50 Disponible en: http://www.nejm.org/doi/full/10.1056/NEJM199408253310802
Serruys PW, et al. Coronary-Artery Stents. N Engl J Med 2006; 354:483-495 Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMra051091
Favaloro RG. Saphenous Vein Autograft Replacement of Severe Segmental Coronary Artery Occlusion Operative Technique. Ann Thorac surg. 1968; 5(4):334-339 Disponible en: http://ats.ctsnetjournals.org/cgi/reprint/5/4/334?ijkey=66373e47c24ec1de8c5ffdc0097f790f7f4b5d54&keytype2=tf_ipsecsha
Poon M, et al. Rapamycin Inhibits Vascular Smooth Muscle Cell Migration. J. Clin. Invest. 1996; 98(10):2277-83 Disponible en: http://www.jci.org/articles/view/119038/files/pdf
Marx SO, et al. Bench to Bedside The Development of Rapamycin and Its Application to Stent Restenosis. Circulation. 2001; 104: 852-855. Disponible en: http://circ.ahajournals.org/content/104/8/852.short
Stettler C, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370(9591):937-948. Disponible en: http://www.thelancet.com/journals/lancet/article/PIIS0140673607614445/abstract
Lasala JM, et al. Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE registry programme. EuroIntervention. 2009; 5:67–77
G. Nakazawa, et al. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis J Am Coll Cardiol. 2009; 54: 1924–1931
Meredith IT, et al. First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I trial EuroIntervention. 2005;1: 157–164
Martínez G, Sánchez N, Suárez A, Díaz O. Biodegradable stents carry out their function and disappear. Medwave. 2010 Oct;10(9):e4776 doi: 10.5867/medwave.2010.09.4776
Serruys PW, et al. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J. 2012; 33 (1): 16-25.
Brugaletta S, et al. Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives Expert Rev. Med. Devices. 2012; 9(4): 327–338.
Garg S, et al. Coronary Stents : Current Status. Cardiology 2010; 56(10):S1-S42 Disponible en: http://www.sciencedirect.com/science/article/pii/S0735109710023715
Garg S, et al. Coronary Stents : Looking Forward. Cardiology 2010; 56(10):S43-S78. Disponible en: http://www.sciencedirect.com/science/article/pii/S0735109710023739
Bakhai A, Hill RA, Dundar Y, Dickson RC, Walley T. Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD004588. DOI: 10.1002/14651858.CD004588.pub3.
Nordmann AJ, Bucher H, Hengstler P, Harr T, Young J. Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD005313. DOI: 10.1002/14651858.CD005313
Greenhalgh J, Hockenhull J, Rao N, Dundar Y, Dickson RC, Bagust A. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Reviews 2010, Issue 3. Article No. CD004587. DOI: 10.1002/14651858. CD004587.pub2. Published Online: January 19, 2010.
Entrevista con Ruben Lamich Betancourt, Médico cirujano, cardiólogo intervencionista desde 1995. Jefe del Departamento de Cardiología de la Clínica Santa María y cardiólogo del Hospital Barros Luco Trudeau en Santiago de Chile. 28 de septiembre de 2012.
Entrevista con Darío Echeverri Arcila, médico cirujano, cardiólogo intervencionista hemodinamista. Jefe Servicio de Hemodinamia e Intervencionismo Cardiovascular. Director Laboratorio de Investigación en Función Vascular. Fundación Cardio Infantil. Bogotá, Colombia